Grifols, S.A. (GRFS)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biopharma	6.49B	6.14B	5.56B	5.01B	3.81B
Diagnostic	640.00M	645.00M	670.00M	671.29M	779.11M
Bio Supplies	154.00M	216.00M	160.00M	146.08M	115.81M
Others	243.00M	208.00M	204.00M	250.17M	266.46M
Intersegments	-	-	-	-8.95M	-43.25M
Total	7.52B	7.21B	6.59B	6.06B	4.93B

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Spain	418.00M	423.00M	363.00M	320.63M	362.41M
Rest of European Union	1.20B	1.08B	893.00M	711.58M	544.04M
USA and Canada	4.25B	4.09B	3.90B	3.86B	3.15B
Rest of World	1.66B	1.63B	1.44B	1.18B	872.12M
Total	7.52B	7.21B	6.59B	6.06B	4.93B

Data Source: S&P Global Market Intelligence Last updated: Jul 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error